Logo
B

BigHat Biosciences

58 employees

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Artificial Intelligence
Therapeutics
Medical

Date founded

2019

Funding rounds raised

Total raised

$75M

from 10 investors over 10 rounds

B

BigHat Biosciences raised $75M on July 20, 2022

Investors: Bristol-Myers Squibb, UK, AME Cloud Ventures, GRIDS Capital, Quadrille Capital, Section 32 and Andreessen Horowitz

B

BigHat Biosciences raised $19M on February 10, 2021

Investors: 8VC, Innovation Endeavors and Andreessen Horowitz

B

BigHat Biosciences raised $5.3M on December 19, 2019

Investors: 8VC

FAQ